SlideShare a Scribd company logo
1 of 31
Surviving Sepsis Campaign: International
Guidelines for Management of Sepsis and
Septic Shock 2021
By:
Dr. Syeda Mishal Saleem
INTRODUCTION
Sepsis is life-threatening organ dysfunction caused by a dysregulated host
response to infection
Sepsis and septic shock are major healthcare problems, impacting millions of
people around the world each year and killing between one in three and one in six
of those it affects.
Early identification and appropriate management in the initial hours after the
development of sepsis improve outcomes.
Sepsis performance improvement programs generally consist of sepsis screening,
education, measurement of sepsis bundle performance, patient outcomes, and actions for identified
opportunities.
Sepsis screening tools :
A variety of clinical variables and tools are used for sepsis screening, such as systemic inflammatory
response syndrome (SIRS) criteria, vital signs, signs of infection, quick Sequential Organ Failure
Score (qSOFA) or Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning
Score (NEWS), or Modified Early Warning Score (MEWS)
SCREENING AND EARLY TREATMENT
Standard operating procedures :
A set of practices known as Early Goal Directed Therapy have evolved to “usual care” which
includes a standard approach with components of the sepsis bundle (1 hour bundle) early
identification.
•Lactate
•Cultures
•Antibiotics
•Fluids
•Vasopressors
The qSOFA uses three variables to predict death and prolonged ICU stay in patients with
known or suspected sepsis:
i.a Glasgow Coma Score < 15
ii.a respiratory rate ≥ 22 breaths/min
iii. a systolic blood pressure ≤ 100mm Hg.
When any two of these variables are present simultaneously, the patient is considered
qSOFA positive.
The association of lactate level with mortality in patients with suspected infection and sepsis is
well established.
Its use is currently recommended as part of the SSC Hour-1 sepsis bundle for those patients with
sepsis.
The lactate cutoffs determining an elevated level ranged from 1.6−2.5 mmol/L.
Sensitivities range from 66−83%, with specificities ranging from 80−85%.
Initial Resuscitation
Timely, effective fluid resuscitation is crucial for the stabilization of sepsis-induced tissue hypoperfusion
in sepsis and septic shock.
The 2016 SSC guideline issued a recommendation for using a minimum of 30mL/kg (ideal body weight)
of IV crystalloids in initial fluid resuscitation. This fixed volume of initial resuscitation was based on
observational evidence.
Most patients require continued fluid administration following initial resuscitation. Such administration needs to
be balanced with the risk of fluid accumulation and potential harm associated with fluid overload and increased
mortality.
 Heart rate, central venous pressure (CVP) and systolic blood pressure alone are poor indicators of fluid
status. Administration of IV fluids guided by jugular venous pressure, respiratory rate, and arterial oxygen
saturation only, was associated with significantly more fluid administration in the first 6 hours and higher
hospital mortality (48.1% versus 33%).
Dynamic measures have demonstrated better diagnostic accuracy at predicting fluid responsiveness
compared with static techniques. These include passive leg raising combined with cardiac output (CO)
measurement, fluid challenges against stroke volume (SV), systolic pressure or pulse pressure, and
increases of SV in response to changes in intrathoracic pressure.
In resource-limited regions where measurement of CO or SV may not be possible, a >15% increase in pulse
pressure could indicate that the patient is fluid responsive utilizing a passive leg-raise test for 60−90 seconds.
If fluid therapy beyond the initial 30mL/kg administration is required, clinicians may use repeated small
boluses guided by objective measures of SV and/or CO.
Serum lactate is an important biomarker of tissue hypoxia and dysfunction, but is not a direct measure
of tissue perfusion. Recent definitions of septic shock include increases in lactate as evidence of cellular
stress to accompany refractory hypotension.
The panel recognizes that normal serum lactate levels are not achievable in all patients with septic
shock, but these studies support resuscitative strategies that decrease lactate toward normal.
When advanced hemodynamic monitoring is not available, alternative measures of organ perfusion
may be used to evaluate the effectiveness and safety of volume administration. Temperature of the
extremities, skin mottling and capillary refill time have been validated and shown to be reproducible signs
of tissue perfusion.
MAP is a key determinant of mean systemic filling pressure, which in turn is the major driver of venous
return and CO. Increasing MAP therefore usually results in increased tissue blood flow and augments the
supply side of tissue perfusion. While some tissues, such as the brain and kidneys have the ability to
autoregulate blood flow.
MAPs below a threshold, usually understood to be approximately 60mm Hg, are associated with decreased
organ perfusion.
Previous SSC guidelines recommended targeting a MAP of greater than 65mm Hg for initial resuscitation.
A meta-analysis of two RCTs on this topic supported that higher MAP targets do not improve survival in
septic shock.
Not much impact on mortality and legth of hospital stay.
Infection
Suspected sepsis or septic shock
Possible septic shock
Possible sepsis without shock
Low likelihood of infection
MRSA cover
MDR
Antifungals
Antivirals
Beta-lactams infusion
Source control
De-escalation of antimicrobials
Albumin, Starches, Gelatin
Hemodnamics
Balanced crystalloids
Inotropic supports
Norepinephrine
Vasopressin and Epinephrine
Terlipressin
Septic shock & Cardiac dysfunction
Invasive arterial monitoring
Peripheral lines
Ventilation (High flow NC/NIV/Invasive)
Tidal volume
Plateau pressure
PEEP
Prone ventilation
Neuromuscular blocking agents
VV- ECMO
Use of steroids:
Stress ulcer prophylaxis
VTE Prophylaxis
Septic shock with AKI
Glucose therapy
Role of vitamin C
Bicarbonate therapy
Enteral nutrition
Post hospital/ ICU Rehabilitation
A 50 year old lady, with no known comorbidities, admitted with fever, productive cough
and shortness of breath. Her initial BP was 80/50mmHg and was given 2L of fluids.
Following this, her vitals were:
Bp: 85/55 mmHg
R/R: 26/min
Heart rate: 110/min
SPO2: 94%@NC (2L/min)
GCS: 13/15 , confused
ABGS showed lactate of 5mmol/L
• Her qSOFA score?
• What is the next most apprpiate step of management?
THANKS!!
1. Weiss SL, Peters MJ, Alhazzani W, et al: Surviving Sepsis Campaign International Guidelines for the Management of Evans et al 1982 www.ccmjournal.org November 2021 •
Volume 49 • Number 11 Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med 2020; 21:e52–e106 2. Pakyz AL, Orndahl CM, Johns A, et
al: Impact of the Centers for Medicare and Medicaid Services Sepsis Core Measure on Antibiotic Use. Clin Infect Dis 2021; 72:556–565 3. Alhazzani W, Evans L, Alshamsi F, et
al: Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med 2021; 49:e219–
e234 4. Levy MM, Pronovost PJ, Dellinger RP, et al: Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med
2004; 32:S595–S597 5. Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;
315:801–810
2. Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
For Meidcal related topics, Contact :
Linkedin: www.linkedin.com/in/dr-mishal-saleem-630a32185

More Related Content

What's hot

Sepsis and septic shock management guidelines 2019
Sepsis and septic shock management guidelines 2019Sepsis and septic shock management guidelines 2019
Sepsis and septic shock management guidelines 2019
razishahid
 
Anesthetic considerations for spinal surgery
Anesthetic considerations for spinal surgeryAnesthetic considerations for spinal surgery
Anesthetic considerations for spinal surgery
Dhritiman Chakrabarti
 
Awake craniotomy
Awake craniotomyAwake craniotomy
Awake craniotomy
vickyyad
 
Anesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repairAnesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repair
Dhritiman Chakrabarti
 

What's hot (20)

Sepsis and septic shock
Sepsis  and septic shockSepsis  and septic shock
Sepsis and septic shock
 
Sepsis
SepsisSepsis
Sepsis
 
Surviving Sepsis Campaign 2021 guidelines.pptx
Surviving Sepsis Campaign 2021 guidelines.pptxSurviving Sepsis Campaign 2021 guidelines.pptx
Surviving Sepsis Campaign 2021 guidelines.pptx
 
Strategies to reduce postoperative pulmonary complications
Strategies to reduce postoperative pulmonary complicationsStrategies to reduce postoperative pulmonary complications
Strategies to reduce postoperative pulmonary complications
 
Sepsis and septic shock management guidelines 2019
Sepsis and septic shock management guidelines 2019Sepsis and septic shock management guidelines 2019
Sepsis and septic shock management guidelines 2019
 
ICU Acquired Weakness
ICU Acquired WeaknessICU Acquired Weakness
ICU Acquired Weakness
 
Wake-Up Stroke (WAKE-UP) trial
Wake-Up Stroke (WAKE-UP) trialWake-Up Stroke (WAKE-UP) trial
Wake-Up Stroke (WAKE-UP) trial
 
Anesthetic considerations for spinal surgery
Anesthetic considerations for spinal surgeryAnesthetic considerations for spinal surgery
Anesthetic considerations for spinal surgery
 
Awake craniotomy
Awake craniotomyAwake craniotomy
Awake craniotomy
 
Management of Sepsis
Management of SepsisManagement of Sepsis
Management of Sepsis
 
PORTAL HTN spleno renal shunt.ppt
PORTAL HTN spleno renal shunt.pptPORTAL HTN spleno renal shunt.ppt
PORTAL HTN spleno renal shunt.ppt
 
Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
 
Sepsis
SepsisSepsis
Sepsis
 
Surviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines UpdatedSurviving Sepsis Guidelines Updated
Surviving Sepsis Guidelines Updated
 
Thromboprophylaxis in icu
Thromboprophylaxis in icuThromboprophylaxis in icu
Thromboprophylaxis in icu
 
Anesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repairAnesthesia for cerebral aneurysm repair
Anesthesia for cerebral aneurysm repair
 
Anesthesia for chronic lung disease
Anesthesia for chronic lung diseaseAnesthesia for chronic lung disease
Anesthesia for chronic lung disease
 
Fluid management and Fluid Responsiveness in ICCU / ICU at ASMIHA workshop 2018
Fluid management and Fluid Responsiveness in ICCU / ICU at ASMIHA workshop 2018Fluid management and Fluid Responsiveness in ICCU / ICU at ASMIHA workshop 2018
Fluid management and Fluid Responsiveness in ICCU / ICU at ASMIHA workshop 2018
 
ICU_Protocol_Management.pdf
ICU_Protocol_Management.pdfICU_Protocol_Management.pdf
ICU_Protocol_Management.pdf
 

Similar to SSC guidelines.ppt

Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
Gaston Droguett
 
Sepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptxSepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptx
samrat277229
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patient
Arun Gupta
 

Similar to SSC guidelines.ppt (20)

Monitoring Fluid Responsiveness in ICU
Monitoring Fluid Responsiveness in ICUMonitoring Fluid Responsiveness in ICU
Monitoring Fluid Responsiveness in ICU
 
49- Sepsis .pptx
49- Sepsis .pptx49- Sepsis .pptx
49- Sepsis .pptx
 
Surviving sepsis campaign highlights 2016
Surviving sepsis campaign  highlights 2016Surviving sepsis campaign  highlights 2016
Surviving sepsis campaign highlights 2016
 
ASandler_Sepsis topic discussion.docx
ASandler_Sepsis topic discussion.docxASandler_Sepsis topic discussion.docx
ASandler_Sepsis topic discussion.docx
 
Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
Vasopressor and inotropic_support_in_septic_shock_an_evidence_based_review_cr...
 
Surviving sepsis
Surviving sepsisSurviving sepsis
Surviving sepsis
 
Chapter 8
Chapter 8Chapter 8
Chapter 8
 
Septic Shock.pptx
Septic Shock.pptxSeptic Shock.pptx
Septic Shock.pptx
 
Role of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd deathRole of autopsy in sepsis relatd death
Role of autopsy in sepsis relatd death
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptxSepsis in surgical patients and its biomarkers.pptx
Sepsis in surgical patients and its biomarkers.pptx
 
Surviving sepsis guidelines
Surviving sepsis guidelinesSurviving sepsis guidelines
Surviving sepsis guidelines
 
Sepsis Guidelines 2007
Sepsis Guidelines 2007Sepsis Guidelines 2007
Sepsis Guidelines 2007
 
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
SURVIVING SEPSIS CAMPAIGN- 2012 to 2016
 
ROSE CONCEPT.pptx
ROSE CONCEPT.pptxROSE CONCEPT.pptx
ROSE CONCEPT.pptx
 
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ingSalon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
Salon a 14 kasim 09.00 10.15 arzu topeli̇ i̇ski̇t-ing
 
Chapter 15
Chapter 15Chapter 15
Chapter 15
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patient
 
Tratamiento del choque septico
Tratamiento del choque septicoTratamiento del choque septico
Tratamiento del choque septico
 
The Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-ImpedanceThe Emerging Role of BIomarkers and Bio-Impedance
The Emerging Role of BIomarkers and Bio-Impedance
 

More from Dr. Mishal Saleem (6)

ABGS Interpretation.pptx
ABGS Interpretation.pptxABGS Interpretation.pptx
ABGS Interpretation.pptx
 
Extra hepatic manifestation of hep C
Extra hepatic manifestation of hep CExtra hepatic manifestation of hep C
Extra hepatic manifestation of hep C
 
Non Cirrhotic Portal Hypertension
Non Cirrhotic Portal HypertensionNon Cirrhotic Portal Hypertension
Non Cirrhotic Portal Hypertension
 
Guide lines for diabetic patients during ramdan
Guide lines for diabetic patients during ramdanGuide lines for diabetic patients during ramdan
Guide lines for diabetic patients during ramdan
 
COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021COPD -- GOLD guidelines REPORT 2021
COPD -- GOLD guidelines REPORT 2021
 
Complications of MI and their managements
Complications of MI and their managementsComplications of MI and their managements
Complications of MI and their managements
 

Recently uploaded

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 

Recently uploaded (20)

DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in India
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 

SSC guidelines.ppt

  • 1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 By: Dr. Syeda Mishal Saleem
  • 2. INTRODUCTION Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection Sepsis and septic shock are major healthcare problems, impacting millions of people around the world each year and killing between one in three and one in six of those it affects. Early identification and appropriate management in the initial hours after the development of sepsis improve outcomes.
  • 3.
  • 4. Sepsis performance improvement programs generally consist of sepsis screening, education, measurement of sepsis bundle performance, patient outcomes, and actions for identified opportunities. Sepsis screening tools : A variety of clinical variables and tools are used for sepsis screening, such as systemic inflammatory response syndrome (SIRS) criteria, vital signs, signs of infection, quick Sequential Organ Failure Score (qSOFA) or Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning Score (NEWS), or Modified Early Warning Score (MEWS) SCREENING AND EARLY TREATMENT
  • 5. Standard operating procedures : A set of practices known as Early Goal Directed Therapy have evolved to “usual care” which includes a standard approach with components of the sepsis bundle (1 hour bundle) early identification. •Lactate •Cultures •Antibiotics •Fluids •Vasopressors
  • 6. The qSOFA uses three variables to predict death and prolonged ICU stay in patients with known or suspected sepsis: i.a Glasgow Coma Score < 15 ii.a respiratory rate ≥ 22 breaths/min iii. a systolic blood pressure ≤ 100mm Hg. When any two of these variables are present simultaneously, the patient is considered qSOFA positive.
  • 7. The association of lactate level with mortality in patients with suspected infection and sepsis is well established. Its use is currently recommended as part of the SSC Hour-1 sepsis bundle for those patients with sepsis. The lactate cutoffs determining an elevated level ranged from 1.6−2.5 mmol/L. Sensitivities range from 66−83%, with specificities ranging from 80−85%.
  • 8.
  • 9. Initial Resuscitation Timely, effective fluid resuscitation is crucial for the stabilization of sepsis-induced tissue hypoperfusion in sepsis and septic shock. The 2016 SSC guideline issued a recommendation for using a minimum of 30mL/kg (ideal body weight) of IV crystalloids in initial fluid resuscitation. This fixed volume of initial resuscitation was based on observational evidence. Most patients require continued fluid administration following initial resuscitation. Such administration needs to be balanced with the risk of fluid accumulation and potential harm associated with fluid overload and increased mortality.
  • 10.  Heart rate, central venous pressure (CVP) and systolic blood pressure alone are poor indicators of fluid status. Administration of IV fluids guided by jugular venous pressure, respiratory rate, and arterial oxygen saturation only, was associated with significantly more fluid administration in the first 6 hours and higher hospital mortality (48.1% versus 33%). Dynamic measures have demonstrated better diagnostic accuracy at predicting fluid responsiveness compared with static techniques. These include passive leg raising combined with cardiac output (CO) measurement, fluid challenges against stroke volume (SV), systolic pressure or pulse pressure, and increases of SV in response to changes in intrathoracic pressure. In resource-limited regions where measurement of CO or SV may not be possible, a >15% increase in pulse pressure could indicate that the patient is fluid responsive utilizing a passive leg-raise test for 60−90 seconds. If fluid therapy beyond the initial 30mL/kg administration is required, clinicians may use repeated small boluses guided by objective measures of SV and/or CO.
  • 11. Serum lactate is an important biomarker of tissue hypoxia and dysfunction, but is not a direct measure of tissue perfusion. Recent definitions of septic shock include increases in lactate as evidence of cellular stress to accompany refractory hypotension. The panel recognizes that normal serum lactate levels are not achievable in all patients with septic shock, but these studies support resuscitative strategies that decrease lactate toward normal. When advanced hemodynamic monitoring is not available, alternative measures of organ perfusion may be used to evaluate the effectiveness and safety of volume administration. Temperature of the extremities, skin mottling and capillary refill time have been validated and shown to be reproducible signs of tissue perfusion.
  • 12. MAP is a key determinant of mean systemic filling pressure, which in turn is the major driver of venous return and CO. Increasing MAP therefore usually results in increased tissue blood flow and augments the supply side of tissue perfusion. While some tissues, such as the brain and kidneys have the ability to autoregulate blood flow. MAPs below a threshold, usually understood to be approximately 60mm Hg, are associated with decreased organ perfusion. Previous SSC guidelines recommended targeting a MAP of greater than 65mm Hg for initial resuscitation. A meta-analysis of two RCTs on this topic supported that higher MAP targets do not improve survival in septic shock.
  • 13. Not much impact on mortality and legth of hospital stay.
  • 14. Infection Suspected sepsis or septic shock Possible septic shock Possible sepsis without shock
  • 15. Low likelihood of infection MRSA cover
  • 21. Terlipressin Septic shock & Cardiac dysfunction Invasive arterial monitoring Peripheral lines
  • 22. Ventilation (High flow NC/NIV/Invasive) Tidal volume Plateau pressure
  • 26. Septic shock with AKI Glucose therapy
  • 27. Role of vitamin C Bicarbonate therapy Enteral nutrition
  • 28. Post hospital/ ICU Rehabilitation
  • 29. A 50 year old lady, with no known comorbidities, admitted with fever, productive cough and shortness of breath. Her initial BP was 80/50mmHg and was given 2L of fluids. Following this, her vitals were: Bp: 85/55 mmHg R/R: 26/min Heart rate: 110/min SPO2: 94%@NC (2L/min) GCS: 13/15 , confused ABGS showed lactate of 5mmol/L • Her qSOFA score? • What is the next most apprpiate step of management?
  • 30. THANKS!! 1. Weiss SL, Peters MJ, Alhazzani W, et al: Surviving Sepsis Campaign International Guidelines for the Management of Evans et al 1982 www.ccmjournal.org November 2021 • Volume 49 • Number 11 Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med 2020; 21:e52–e106 2. Pakyz AL, Orndahl CM, Johns A, et al: Impact of the Centers for Medicare and Medicaid Services Sepsis Core Measure on Antibiotic Use. Clin Infect Dis 2021; 72:556–565 3. Alhazzani W, Evans L, Alshamsi F, et al: Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med 2021; 49:e219– e234 4. Levy MM, Pronovost PJ, Dellinger RP, et al: Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 2004; 32:S595–S597 5. Singer M, Deutschman CS, Seymour CW, et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801–810 2. Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
  • 31. For Meidcal related topics, Contact : Linkedin: www.linkedin.com/in/dr-mishal-saleem-630a32185